including our most recent Annual Report on Form 10-K, Quarterly
Reports on Form 10-Q, and current reports on Form 8-K. We claim the
protection of the safe harbor contained in the Private Securities Reform
Act of 1995 for forward-looking statements. We are providing this
information as of November 1, 2007, and assume no obligation to update or
revise the information contained in this press release whether as a result
of new information, future events or any other reason. [uthr-g]
Remodulin and HeartBar are registered trademarks of United Therapeutics
Corporation.
Beraprost is a trademark of Toray Industries, Inc.
OvaRex is a registered trademark of AltaRex Medical Corp.
UNITED THERAPEUTICS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
(Unaudited) (Unaudited)
Revenues:
Net product sales $56,661 $38,931 $144,449 $109,301
Service sales 1,718 1,466 5,263 4,505
Distributor fees 666 - 1,333 -
Total revenues $59,045 40,937 151,045 113,806
Operating expenses:
Research and development 19,559 11,919 54,629 39,233
Research and development
expense related
to issuance of stock - - 11,013 -
Selling, general
and administrative 19,163 12,891 54,801 34,841
Impairment of
HeartBar tradename - - - 2,024
Cost of produc
'/>"/>
SOURCE United Therapeutics Corporation Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1.
Inacom Education earns Wisconsin membership in United Training2.
Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO3.
TomoTherapy reports 86% revenue jump, $131M net loss in Q14.
Sonic Foundry reports GAAP loss as Q2 revenues rise5.
Fiserv reports $113.5 million in Q1 profit6.
Third Wave reports net loss of $18.9M for 20067.
Musicnotes reports 45 percent growth in 20068.
Sonic Foundry reports net loss, higher revenue9.
Sonic Foundry reports first cash-positive quarter10.
Merge Healthcare reports $10.8M net loss in Q311.
Third Wave reports $5.2M third quarter loss